Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MEFO: Preoperative Endoscopic Antibiotics for Right-sided Colon Cancer and Adenoma
NCT04312360Phase 2Completed
- Sponsor
- Zealand University Hospital
- Start
- Jan 2020
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fosfomycin, metronidazole in colon cancer, colon adenoma, sponsored by Zealand University Hospital. Started Jan 2020; status: completed.
02
Drugs
fosfomycinmetronidazole
03
Conditions
colon cancercolon adenoma
Beyond the preview
Go deeper on NCT04312360.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04312360.